ArticleG3 (Bethesda, Md.)2026
Regulation of hlh-2 transcription during specification of the anchor cell of the C. elegans hermaphrodite gonad.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The anchor cell (AC) of the Caenorhabditis elegans hermaphrodite somatic gonad primordium is a signaling nexus that regulates uterine and vulval development. As the somatic gonad primordium is forming, four cells, two α and two β cells, are born with the potential to be the AC. This potential becomes restricted to the α cells, which undergo the LIN-12/Notch-mediated AC/VU decision to resolve which α cell will become the AC. The transcription factor HLH-2, the sole E/Daughterless protein ortholog in C. elegans, is critical for this process, and dynamic regulation of hlh-2 transcription contributes to the robust specification of a single AC. The hlh-2prox regulatory element mediates the dynamic pattern of hlh-2 transcription: the initial expression in the parents of the α and β cells, which is briefly sustained in the α and β cells after they are born; its subsequent restriction to the α cells during the AC/VU decision; and its continued expression in the AC. In this study, we identify the cis-acting sequences within hlh-2prox and transcription factors required for the initial expression of hlh-2 in the α and β cells and their parents, demonstrate that the Wnt/β-catenin Asymmetry Pathway (WβA) regulates restriction of hlh-2 transcription to the α cells, and show that the maintenance of hlh-2 transcription in α cells requires distinct elements and the chromatin factor LSY-12. This analysis extends our understanding of regulatory mechanisms that operate during a precise and robust Notch-mediated lateral specification paradigm.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.